Mark Vignola ā€” Executive Director, Head of Corporate Development & Investor Relations at Intercept Pharmaceuticals | Comparably
Comparably
Intercept Pharmaceuticals
Intercept Pharmaceuticals develops small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. read more
EMPLOYEE
PARTICIPANTS
8
TOTAL
RATINGS
21
Mark Vignola ā€” Executive Director, Head of Corporate Development & Investor Relations at Intercept Pharmaceuticals

Mark Vignola ā€” Executive Director, Head of Corporate Development & Investor Relations at Intercept Pharmaceuticals

Executive Bio

Mark Vignola serves as the Executive Director, Head of Corporate Development & Investor Relations of Intercept Pharmaceuticals. Mark started at Intercept Pharmaceuticals in January of 2018. Mark currently resides in the Greater New York City Area.

Executive Team Culture Ratings from Intercept Pharmaceuticals Employees

?
Not enough data
See Detailed Executive Team Ratings
Who ranks the Executive Team the highest?
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Intercept Pharmaceuticals
Who ranks the Executive Team the lowest?
Not Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Intercept Pharmaceuticals

Intercept Pharmaceuticals' Executive Team at a Glance

Intercept Pharmaceuticals' Executive Team does not have any ratings yet.

×
Rate your company